The First People's Hospital of Jingzhou   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Jingzhou China (1949)

Organization Overview

First Clinical Trial
2014
NCT02999048
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

The First People's Hospital of Jingzhou

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 2)

Colorectal Neoplasms (Phase 2)

Hematoma (Phase 4)

Hemorrhage (Phase 4)

Intracranial Hemorrhage, Hypertensive (Phase 4)

Lung Neoplasms (Phase 2)

Rectal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 12